TP53 and cancer: Interestingly, mutant p53 (p53-R273H), which loses its oncosuppressive activity and acquires oncogenic properties [120], was shown to inhibit Bmf expression through activation of the PI3K/AKT signaling cascade in various cancer types [121], which corresponds with the previously mentioned report concerning the negative influence of this pathway on Bmf function [55].